Malignant Melanoma in Early-Treated Parkinson's Disease: The NET-PD Trial

BACKGROUND: The risk for malignant melanoma is higher than expected in Parkinson's disease (PD). The National Institutes of Health (NIH) Exploratory Trials in PD (NET-PD) Long-term Study 1 (LS-1) trial is a contemporary phase 3 study of subjects with early, treated PD. The objective of this wor...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mov Disord
Asıl Yazarlar: Constantinescu, Radu, Elm, Jordan, Auinger, Peggy, Sharma, Saloni, Augustine, Erika F., Khadim, Laith, Kieburtz, Karl
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4375545/
https://ncbi.nlm.nih.gov/pubmed/24323565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25734
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller